参考文献/References:
[1]胡盛寿,高润霖,刘力生,等. 《中国心血管病报告2018》概要[J]. 中国循环杂志, 2019,34(3):209-220.
[2]朱佳琳. 移动健康医疗在改善心血管疾病患者依从性中的作用[J]. 心血管病学进展,2017,38(6):635-639.
[3]Walsh JA,Topol EJ,Steinhubl SR. Novel wireless devices for cardiac monitoring[J]. Circulation,2014,130(7):573-581.
[4]Gladstone DJ,Spring M,Dorian P,et al. Atrial fibrillation in patients with cryptogenic stroke[J]. N Engl J Med,2014,370(26):2467-2477.
[5]Kirchhof P,Benussi S,Kotecha D,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Rev Esp Cardiol (Engl Ed),2017,70(1):50.
[6]Ramkumar S,Nerlekar N,D’Souza D,et al. Atrial fibrillation detection using single lead portable electrocardiographic monitoring:a systematic review and meta-analysis[J]. BMJ Open,2018,8(9):e024178.
[7]Steinberg C,Philippon F,Sanchez M,et al. A novel wearable device for continuous ambulatory ECG recording:proof of concept and assessment of signal quality[J]. Biosensors,2019,9(1).pii: E17.
[8]D?rr M,Nohturfft V,Brasier N,et al. The WATCH AF trial:smartwatches for?detection?of?atrial fibrillation[J]. JACC Clin Electrophysiol,2019,5(2):199-208.
[9]Bumgarner JM,Lambert CT,Hussein AA,et al. Smartwatch algorithm for automated?detection of atrial fibrillation[J]. J Am Coll Cardiol,2018,71(21):2381-2388.
[10] Maurizi N,Faragli A,Imberti J,et al. Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart?)[J]. Int J Cardiol,2017,236:249-252.
[11] Castelletti S,Dagradi F,Goulene K,et al. A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome[J]. Int J Cardiol,2018,266:89-94.
[12] Al-Khatib SM,Stevenson WG,Ackerman MJ,et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death:executive summary[J]. Circulation,2018,138(13):e210-e271.
[13] Chieng D,Paul V,Denman R. Current device therapies for sudden cardiac death prevention—the ICD,subcutaneous ICD and wearable ICD[J]. Heart Lung Circ,2019,28(1):65-75.
[14] Chung MK,Szymkiewicz SJ,Shao M,et al. Aggregate national experience with the wearable cardioverter-defibrillator:event rates,compliance,and survival[J]. J Am Coll Cardiol,2010,56(3):194-203.
[15] Daimee UA,Vermilye K,Moss AJ,et al. Experience with the wearable cardioverter-defibrillator in older patients:results from the prospective registry of patients using the wearable cardioverter-defibrillator[J]. Heart Rhythm,2018,15(9):1379-1386.
[16] Olgin JE,Pletcher MJ,Vittinghoff E,et al. Wearable cardioverter-defibrillator after myocardial infarction[J]. N Engl J Med,2018,379(13):1205-1215.
[17] Lenarczyk R,Potpara TS,Haugaa KH,et al. The use of wearable cardioverter-defibrillators in Europe:results of the European Heart Rhythm Association survey[J]. Europace,2016,18(1):146-150.
[18] Brahmbhatt DH,Cowie MR. Remote management of heart failure:an overview of telemonitoring technologies[J]. Card Fail Rev,2019,5(2):86-92.
[19] Mondritzki T,Boehme P,White J,et al. Remote left ventricular hemodynamic monitoring using a novel intracardiac sensor[J]. Circ Cardiovasc Interv,2018,11(5):e006258.
[20] Abraham WT,Adamson PB,Bourge RC,et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure:a randomised controlled trial[J]. Lancet,2011,377(9766):658-666.
[21] Tripoliti EE,Karanasiou GS,Ioannidou P,et al. KardiaTool:an integrated POC solution for non-invasive diagnosis and therapy monitoring of heart failure patients[J]. Conf Proc IEEE Eng Med Biol Soc,2018 ,2018:3878-3881.
[22] Forouzanfar MH,Liu P,Roth GA,et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg,1990-2015[J]. JAMA,2017,317(2):165-182.
[23] Wang Z,Chen Z,Zhang L,et al. Status of Hypertension in China:Results From the China Hypertension Survey,2012-2015[J]. Circulation,2018,137(22):2344-2356.
[24] Zheng Y,Poon CC,Yan BP,et al. Pulse arrival time based cuff-less and 24-h wearable blood pressure monitoring and its diagnostic value in hypertension[J]. J Med Syst,2016 ,40(9):195.
[25] Zhang Q,Zhou D,Zeng X. Highly wearable cuff-less blood pressure and heart rate monitoring with single-arm electrocardiogram and photoplethysmogram signals[J]. Biomed Eng Online,2017,16(1):23.
[26] Narasimhan R,Parlikar T,Verghesel G,et al. Finger-wearable blood pressure monitor[J]. Conf Proc IEEE Eng Med Biol Soc,2018,2018:3792-3795.
[27] Kuwabara M,Harada K,Hishiki Y,et al. Validation of two watch-type wearable blood pressure monitors according to the ANSI/AAMI/ISO81060-2:2013 guidelines:Omron HEM-6410T-ZM and HEM-6410T-ZL[J]. J Clin Hypertens (Greenwich),2019,21(6):853-858.
[28] Abegaz TM,Shehab A,Gebreyohannes EA,et al. Nonadherence to antihypertensive drugs:a systematic review and meta-analysis[J]. Medicine,2017,96(4):e5641.
[29] Frias J,Virdi N,Raja P,et al. Effectiveness of digital medicines to improve clinical outcomes in patients with uncontrolled hypertension and type 2 diabetes:prospective,open-label,cluster-randomized pilot clinical trial[J]. J Med Internet Res,2017,19(7):e246.
[30] Lee Y,Howe C,Mishra S,et al. Wireless,intraoral hybrid electronics for real-time quantification of sodium intake toward hypertension management[J]. Proc Natl Acad Sci U S A,2018,115(21):5377-5382.
[31] Lai LS,Redington AN,Reinisch AJ,et al. Computerized automatic diagnosis of innocent and pathologic murmurs in pediatrics:a pilot study[J]. Congenit Heart Dis,2016,11(5):386-395.
[32] Chowdhury MEH,Khandakar A,Alzoubi K,et al. Real-time smart-digital stethoscope system for heart diseases monitoring[J]. Sensors (Basel),2019,19(12).pii: E2781.
[33] MacKinnon GE,Brittain EL. Mobile health technologies in cardiopulmonary disease[J]. Chest,2019,Oct 31.pii: S0012-3692(19)34117-0.
[34]余湘. 基于移动医疗的高血压个案管理[J]. 心血管病学进展,2018,39(6):926-929.